קנדה - אנגלית - Health Canada

jamp pharma corporation - mycophenolic acid (mycophenolate sodium) - tablet (enteric-coated) - 360mg - mycophenolic acid (mycophenolate sodium) 360mg - immunosuppressive agents

קנדה - אנגלית - Health Canada

jamp pharma corporation - mycophenolic acid (mycophenolate sodium) - tablet (enteric-coated) - 180mg - mycophenolic acid (mycophenolate sodium) 180mg - immunosuppressive agents

ישראל - אנגלית - Ministry of Health

ofek pharma ltd, israel - mycophenolic acid - tablets delayed release - mycophenolic acid 180 mg - mycophenolic acid - mycophenolic acid is indicated in combination with ciclosporin and corticosteroids for the prophylaxis of acute transplant rejection in adult patients receiving allogeneic renal transplants.

ישראל - אנגלית - Ministry of Health

ofek pharma ltd, israel - mycophenolic acid - tablets delayed release - mycophenolic acid 360 mg - mycophenolic acid - mycophenolic acid is indicated in combination with ciclosporin and corticosteroids for the prophylaxis of acute transplant rejection in adult patients receiving allogeneic renal transplants.

ארצות הברית - אנגלית - NLM (National Library of Medicine)

novartis pharmaceuticals corporation - mycophenolate sodium (unii: wx877sqi1g) (mycophenolic acid - unii:hu9dx48n0t) - mycophenolic acid 360 mg - myfortic® (mycophenolic acid) is indicated for the prophylaxis of organ rejection in adult patients receiving a kidney transplant. myfortic is indicated for the prophylaxis of organ rejection in pediatric patients 5 years of age and older who are at least 6 months post kidney transplant. myfortic is to be used in combination with cyclosporine and corticosteroids. myfortic delayed-release tablets and mycophenolate mofetil (mmf) tablets and capsules should not be used interchangeably without physician supervision because the rate of absorption following the administration of these two products is not equivalent. myfortic is contraindicated in patients with a hypersensitivity to mycophenolate sodium, mycophenolic acid (mpa), mycophenolate mofetil, or to any of its excipients. reactions like rash, pruritus, hypotension, and chest pain have been observed in clinical trials and post marketing reports [see adverse reactions (6)] . pregnancy exposure registry there is a pregnancy exposure registry that monitors preg

קנדה - אנגלית - Health Canada

sandoz canada incorporated - mycophenolic acid (mycophenolate sodium) - tablet (enteric-coated) - 180mg - mycophenolic acid (mycophenolate sodium) 180mg - immunosuppressive agents

קנדה - אנגלית - Health Canada

sandoz canada incorporated - mycophenolic acid (mycophenolate sodium) - tablet (enteric-coated) - 360mg - mycophenolic acid (mycophenolate sodium) 360mg - immunosuppressive agents

מלזיה - אנגלית - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

accord healthcare sdn.bhd. - mycophenolic acid (as sodium salt) -

מלזיה - אנגלית - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

accord healthcare sdn.bhd. - mycophenolic acid (as sodium salt) -

טנזניה - אנגלית - Tanzania Medicinces & Medical Devices Authority

intas pharmaceuticals limited, india - mycophenolic acid - oral tablet - 360